Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents.
Recent advances in molecular and genomic techniques have facilitated research on several aspects of mycobacteriology, such as diagnosis and the identification of new vaccines and therapeutic targets for various diseases, including tuberculosis. The aim of this review was to analyze the implications of advances in molecular and genomic techniques on the development of new vaccines for tuberculosis as well as immunological reagents to diagnose the disease. Gene cloning and expression, DNA and protein sequencing, polymerase chain reaction, comparative genomics, bioinformatics, proteomics and DNA and peptide synthesis coupled with the application of cellular immunology techniques have led to the identification of several antigens of Mycobacterium tuberculosis, which have potential for diagnosis and vaccine applications. For example, cross-reactive mycobacterial antigens like heat shock proteins, MTB32 and MTB39, have been identified as new vaccine candidates, and antigens encoded by M. tuberculosis-specific genomic regions as new reagents for diagnosis.
Mustafa
A S
AS
Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait. abusalim@hsc.kuniv.edu.kw
D000942:Antigens, Bacterial / Q000235:genetics / Q000276:immunology; D001428:Bacterial Vaccines / Q000235:genetics*; D003001:Cloning, Molecular; D019295:Computational Biology / Q000639:trends; D015964:Gene Expression Regulation, Bacterial; D005827:Genetics, Microbial / Q000639:trends*; D006801:Humans; D008967:Molecular Biology / Q000639:trends; D009169:Mycobacterium tuberculosis / Q000235:genetics* / Q000276:immunology; D040901:Proteomics / Q000639:trends; D011933:Reagent Kits, Diagnostic
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D011933:Reagent Kits, Diagnostic